Benzinga Rankings give you vital metrics on any stock – anytime.
Explore ProPhase Labs stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PRPH.
You can purchase shares of ProPhase Labs (NASDAQ:PRPH) through any online brokerage.
Other companies in ProPhase Labs’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), 60 Degrees (NASDAQ:SXTP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
ProPhase Labs has a consensus price target of $11.00.
The stock price for ProPhase Labs (NASDAQ: PRPH) is $0.2836 last updated April 17, 2025 at 4:23 PM EDT.
A quarterly cash dividend of 0.30 per share of Class A Common Stock. The quarterly cash dividend was payable on June 3, 2022 to stockholders of record on May 24, 2022.
ProPhase Labs’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for ProPhase Labs.
ProPhase Labs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.